Delivery Order SPE2DB20D9331-SPE2DB25FL0C5

Award Date 10/7/24
Potential Completion Date 10/29/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,758.60 delivery order is for the supply of VELCADE 3.5 MG VIALS, a specialty oncology medication. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,988.64 firm fixed-price contract is for the delivery of VELCADE 3.5 MG VIALS to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,314.40 firm-fixed-price contract is for the delivery of VELCADE 3.5 mg vials to support the recurring medical supply needs of military health facilities. The award is associated with a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,160.04 firm fixed-price contract is for the supply of 3.5 mg VELCADE vials, with a period of performance through May 1, 2024. The award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,732.75 contract is for the supply of Velcade 3.5 mg vials, a specialized oncology medication. The award is not associated with a specific set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,465.50, is for the delivery of 3.5 milligram vials of the drug Velcade. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December...
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract valued at $11,434.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4559578220 VELCADE 3.5 MG VIALS, with a completion date of January 26, 2023. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the Defense Logistics Agency under the SPE2DB program, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $22,868.60, is for the procurement of VELCADE 3.5 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, valued at up to $499,999,999, which runs through December 31,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, valued at up to $499,999,999, covers a comprehensive range of pharmaceutical products to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The $22,877.20 delivery order is for VELCADE 3.5 MG...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,931 contract is for the delivery of 3.5 mg vials of the prescription drug Velcade. This delivery order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA to provide a comprehensive range of branded and generic...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB25FL0C5
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is part of a larger single-award indefinite delivery contract (IDC) with the DLA worth up to $499,999,999, which runs through December 31, 2025.

The current delivery order is for $11,657.20 and is for the supply of 3.5 mg vials of the drug VELCADE. This order is placed under a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the medical needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities nationwide.

Generated 1/9/25, 9:27 AM